GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLM) » Definitions » Other Gross PPE

Apollomics (Apollomics) Other Gross PPE : $0.14 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Other Gross PPE?

Apollomics's Other Gross PPE for the quarter that ended in Dec. 2023 was $0.14 Mil.

Apollomics's quarterly Other Gross PPE increased from Dec. 2022 ($0.14 Mil) to Jun. 2023 ($0.68 Mil) but then declined from Jun. 2023 ($0.68 Mil) to Dec. 2023 ($0.14 Mil).

Apollomics's annual Other Gross PPE declined from Dec. 2021 ($0.14 Mil) to Dec. 2022 ($0.14 Mil) but then increased from Dec. 2022 ($0.14 Mil) to Dec. 2023 ($0.14 Mil).

Apollomics Other Gross PPE Historical Data

The historical data trend for Apollomics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Other Gross PPE Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Gross PPE
0.12 0.14 0.14 0.14

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Gross PPE Get a 7-Day Free Trial 0.14 1.33 0.14 0.68 0.14

Apollomics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLM) » Definitions » Other Gross PPE
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLMW:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.